Skip to main content

Streamex Corp.

STEX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001530766

In the last 90 days, Streamex Corp. insiders filed 0 open-market purchases and 1 sale; 53 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Streamex Corp. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of STEX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders66152−13
Shares5.13M100.9K4.85M−177.9K (−3.5%)
Value$19.8M$389.0K$14.5M−$4.93M (−25.4%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Streamex Corp. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to STEX in Q3 2021
InstitutionSharesValue% of portfolio
Citadel Advisors LLC41,912$125.0K0.00%
First Horizon Advisors, Inc.10,000$30.0K0.00%
Geneos Wealth Management Inc.1,640$4.00K0.00%

Sold out (16)

Institutions that held Streamex Corp. at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (1)

Institutions that held Streamex Corp. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STEX in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Mayo Clinic100,891$389.0K